Dyrk1A-IN-10

• UNSPSC Description:

  Dyrk1A-IN-10 (compound B4) is a DYRK1A inhibitor with antidiabetic activity. Dyrk1A-IN-10 can promote pancreatic β-cell proliferation, increase insulin secretion, and lower blood sugar[1].

• Target Antigen:

  DYRK

• Type:

  Reference compound

• Related Pathways:

  Protein Tyrosine Kinase/RTK

• Field of Research:

  Metabolic Disease

• Assay Protocol:

  https://www.medchemexpress.com/dyrk1a-in-10.html

• Smiles:

  O=C(N(C1C)CCC2=C1NC3=C2C=C(OC)C=C3)/C=C/C4=CC=C(Cl)C=C4

• Molecular Weight:

  380.87

• References & Citations:

  [1]Li Guan, et al. "Design, synthesis, and biological evaluation of β-carboline-cinnamic acid derivatives as DYRK1A inhibitors in the treatment of diabetes." Bioorganic Chemistry (2024): 107676.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2891824-14-7